Bonus BioGroup Ltd. (TLV:BONS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 24.90
+0.20 (0.81%)
At close: Dec 4, 2025
Bonus BioGroup Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -25.52 | -27.83 | -28.53 | -38.7 | -90.08 | -22.02 | Upgrade
|
| Depreciation & Amortization | 2.78 | 2.79 | 2.76 | 2.66 | 1.48 | 1.07 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 7.9 | 20.98 | 2.15 | Upgrade
|
| Stock-Based Compensation | 1.4 | 1.63 | 1.45 | 7.6 | 9.85 | 2.75 | Upgrade
|
| Other Operating Activities | 0.21 | -0.05 | -0.75 | -6.93 | 26.34 | -0.02 | Upgrade
|
| Change in Accounts Receivable | -0.71 | 0.13 | 0.35 | 0.36 | -0.52 | -0.45 | Upgrade
|
| Change in Accounts Payable | -0.38 | -0.26 | -0.38 | -2.35 | 2.44 | 0.08 | Upgrade
|
| Change in Other Net Operating Assets | 3.92 | 2.2 | -1.3 | 0.64 | -10.33 | 0.69 | Upgrade
|
| Operating Cash Flow | -18.3 | -21.37 | -26.4 | -28.82 | -39.84 | -15.75 | Upgrade
|
| Capital Expenditures | -0.08 | -0.34 | -0.82 | -6.39 | -5.81 | -0.25 | Upgrade
|
| Investment in Securities | - | 13 | -13.43 | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | 0.1 | -0.37 | - | Upgrade
|
| Investing Cash Flow | -0.08 | 12.65 | -14.26 | -6.29 | -6.18 | -0.25 | Upgrade
|
| Long-Term Debt Repaid | - | -1.3 | -1.16 | -1.2 | -1.65 | -0.67 | Upgrade
|
| Total Debt Repaid | -1.4 | -1.3 | -1.16 | -1.2 | -1.65 | -0.67 | Upgrade
|
| Net Debt Issued (Repaid) | -1.4 | -1.3 | -1.16 | -1.2 | -1.65 | -0.67 | Upgrade
|
| Issuance of Common Stock | 7.05 | 3.85 | - | 3.34 | 111.35 | 32.59 | Upgrade
|
| Other Financing Activities | - | - | - | - | 3.72 | - | Upgrade
|
| Financing Cash Flow | 5.65 | 2.55 | -1.16 | 2.14 | 113.42 | 31.92 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.21 | 0.09 | 1.12 | 7.05 | -3.94 | 0.06 | Upgrade
|
| Net Cash Flow | -12.95 | -6.08 | -40.69 | -25.93 | 63.46 | 15.98 | Upgrade
|
| Free Cash Flow | -18.38 | -21.72 | -27.22 | -35.2 | -45.65 | -16 | Upgrade
|
| Free Cash Flow Per Share | - | -0.02 | -0.02 | -0.03 | -0.04 | -0.02 | Upgrade
|
| Cash Interest Paid | 0.76 | 0.8 | 0.86 | 0.9 | 0.34 | 0.41 | Upgrade
|
| Levered Free Cash Flow | -9.04 | -11.84 | -17.26 | -20.47 | -44.15 | -8.53 | Upgrade
|
| Unlevered Free Cash Flow | -8.52 | -11.35 | -16.73 | -19.91 | -43.8 | -8.27 | Upgrade
|
| Change in Working Capital | 2.83 | 2.08 | -1.33 | -1.35 | -8.41 | 0.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.